Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...

WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and ...

Some lots of the SYMJEPI epinephrine syringes used for emergency treatment of allergic reactions have been recalled because the needle may clog. Adamis Pharmaceuticals Corp. has recalled some 0.15 mg ...

Please provide your email address to receive an email when new articles are posted on . Fears of pain or misuse may cause delays in autoinjector use during anaphylaxis. Patients experienced higher ...

The pharmacodynamics profile for 13.2-mg IN epinephrine in the opposite or same nostrils was comparable to that of the 0.3-mg autoinjector and 0.5-mg manual syringe. Intranasal (IN) epinephrine is ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 16, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's New Drug ...